好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Mitochondrial Coupling Defect in Fibroblasts from Patients with Mfn2-Related Charcot-Marie-Tooth Type 2a
Neurogenetics and Gene Therapy
(-)
052
Authors/Disclosures
Christophe Verny (CHU Charcot) No disclosure on file
No disclosure on file
No disclosure on file
James Baier No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
William Mack William Mack has received personal compensation for serving as an employee of NFL. William Mack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Imperative Care. The institution of William Mack has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vanderbilt University (Stryker study) . William Mack has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. William Mack has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goza and Honnald LLC. William Mack has stock in egret therapeutics. William Mack has stock in Borvo. William Mack has stock in Radical Catheters. William Mack has stock in Vastrax. William Mack has stock in Q'Apel. William Mack has stock in Viseon. William Mack has stock in Stream Biomedical. William Mack has stock in Spartan Micro. William Mack has stock in Endostream. The institution of William Mack has received research support from National Institutes of Health.
Patrizia Amati-Bonneau (Departement de Biochimie et Genetique) No disclosure on file
Frederic Dubas, PrMD No disclosure on file
No disclosure on file
Dominique Bonneau (Departement de Biochimie et Genetique) No disclosure on file